Metraipolis › archive › dc_d4e9aeff5164

Alternative Splicing-Mediated Resistance to Antibody-Based Therapies: Mechanisms and Emerging Therapeutic Strategies — Europe PMC PMID:41465349

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41465349
DOI
10.3390/ijms262411918
License (as archived)
solo-consultazione
Archived
2026-11-07T18:25:56.306Z
SHA-256 of the archived text
46bff75288e512122f3fe073d3740642d1b8be591e4be4c8ff11ebf06bcf1f11
Stable URL of this page
https://metraipolis.com/documento/dc_d4e9aeff5164

How to cite

Alternative Splicing-Mediated Resistance to Antibody-Based Therapies: Mechanisms and Emerging Therapeutic Strategies — Europe PMC PMID:41465349 — Europe PMC (en), https://europepmc.org/article/MED/41465349 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d4e9aeff5164 (Metraipolis archive dc_d4e9aeff5164, sha256 46bff75288e512122f3fe073d3740642d1b8be591e4be4c8ff11ebf06bcf1f11)
BibTeX
@misc{dcd4e9aeff5164,
  title = {Alternative Splicing-Mediated Resistance to Antibody-Based Therapies: Mechanisms and Emerging Therapeutic Strategies — Europe PMC PMID:41465349},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41465349},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d4e9aeff5164; sha256 46bff75288e512122f3fe073d3740642d1b8be591e4be4c8ff11ebf06bcf1f11},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41465349. Agents can read the archived copy with the MCP tool read_document.